Abstract: The present invention relates to the inhibition of stress-induced receptor tyrosine kinase activity by inhibiting a ligand of said receptor tyrosine kinase, particularly an extracellular ligand.
Type:
Application
Filed:
July 5, 2004
Publication date:
July 6, 2006
Applicant:
Max-Planck-Gesellschaft zur Foerderung der Wessenschaften. E.V.